Literature DB >> 19658093

Thymic stromal lymphopoietin is a critical mediator of IL-13-driven allergic inflammation.

Masanori Miyata1, Yuki Nakamura, Naomi Shimokawa, Yuko Ohnuma, Ryohei Katoh, Shuji Matsuoka, Ko Okumura, Hideoki Ogawa, Keisuke Masuyama, Atsuhito Nakao.   

Abstract

Both thymic stromal lymphopoietin (TSLP) and IL-13 are essential cytokines for the development of allergic inflammation. However, a causal link between TSLP and IL-13 has not yet been fully elucidated. This study aimed to investigate whether IL-13 induces TSLP expression and whether the induction contributes to the development of allergic inflammation. We found that IL-13 induced TSLP expression in mouse nasal tissue specimens in a Stat6-dependent manner. In addition, intranasal challenge of mice with IL-13 induced TSLP expression in the nasal epithelium. Importantly, intranasal IL-13 challenge induced eosinophilia and goblet cell hyperplasia in the nasal mucosa in mice, which was inhibited by the blockade of TSLP activity with anti-TSLP Ab. These findings suggest that TSLP is an important mediator of IL-13-driven allergic inflammation in the nasal mucosa. Taken together with the recent findings that IL-13 is a critical downstream element for TSLP-driven allergic inflammation, TSLP may function both upstream and downstream of IL-13, thus providing an additional rationale as to why TSLP plays such a central role in the development of allergic inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19658093     DOI: 10.1002/eji.200939302

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

Review 1.  The regulation of thymic stromal lymphopoietin in gut immune homeostasis.

Authors:  Ming Li; Ji Zhang; Yuzhang Wu; Jintao Li
Journal:  Dig Dis Sci       Date:  2011-02-12       Impact factor: 3.199

Review 2.  Thymic stromal lymphopoietin and allergic disease.

Authors:  Steven F Ziegler
Journal:  J Allergy Clin Immunol       Date:  2012-08-30       Impact factor: 10.793

3.  Tumor necrosis factor superfamily 14 (LIGHT) controls thymic stromal lymphopoietin to drive pulmonary fibrosis.

Authors:  Rana Herro; Ricardo Da Silva Antunes; Amelia Roman Aguilera; Koji Tamada; Michael Croft
Journal:  J Allergy Clin Immunol       Date:  2015-02-11       Impact factor: 10.793

Review 4.  Gene expression signatures: a new approach to understanding the pathophysiology of chronic rhinosinusitis.

Authors:  Chunwei Li; Li Shi; Yan Yan; Bruce R Gordon; William M Gordon; De-Yun Wang
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.806

5.  TSLP promotes induction of Th2 differentiation but is not necessary during established allergen-induced pulmonary disease.

Authors:  Sihyug Jang; Susan Morris; Nicholas W Lukacs
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

Review 6.  Mast cells in allergic asthma and beyond.

Authors:  Sebastian Reuter; Michael Stassen; Christian Taube
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

7.  The glycosylation pattern of common allergens: the recognition and uptake of Der p 1 by epithelial and dendritic cells is carbohydrate dependent.

Authors:  Abeer Al-Ghouleh; Ramneek Johal; Inas K Sharquie; Mohammed Emara; Helen Harrington; Farouk Shakib; Amir M Ghaemmaghami
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

8.  Livin in synergy with Ras induces and sustains corticosteroid resistance in the airway mucosa.

Authors:  Jin-Mei Xue; Yun-Fang An; Li-Min Suo; Li-Hua Mo; Gui Yang; Xiang-Qian Luo; Da-Bo Liu; Chang-Qing Zhao; Ping-Chang Yang
Journal:  Int J Biol Sci       Date:  2021-05-13       Impact factor: 6.580

9.  The in vivo fibrotic role of FIZZ1 in pulmonary fibrosis.

Authors:  Tianju Liu; Hongfeng Yu; Matthew Ullenbruch; Hong Jin; Toshihiro Ito; Zhe Wu; Jianhua Liu; Sem H Phan
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240

10.  Food allergy in mice is modulated through the thymic stromal lymphopoietin pathway.

Authors:  Christophe P Frossard; Simone C Zimmerli; José M Rincon Garriz; Philippe A Eigenmann
Journal:  Clin Transl Allergy       Date:  2016-01-19       Impact factor: 5.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.